Christopher Yau

Has grant

University of Oxford
Country flagUnited Kingdom

Research Interests

Explore related searches

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Recent Grants

Grant: Close

Turing AI Fellowship: clinAIcan - developing clinical applications of artificial intelligence for cancer

Open Date: 2022-03-01

Close Date: 2025-12-31

Grant: Close

Interpretable statistical machine learning approaches for the molecular investigation of cancer

Open Date: 2021-09-30

Close Date: 2025-09-29

Grant: Close

Multimorbidity and Pregnancy: Determinants, Clusters, Consequences and Trajectories (MuM-PreDiCT)

Open Date: 2021-08-31

Close Date: 2024-08-30

Grant: Close

Turing AI Fellowship: clinAIcan - developing clinical applications of artificial intelligence for cancer

Open Date: 2021-01-01

Close Date: 2022-02-28

Grant: Open

The HDRUK/Turing Wellcome PhD Programme in Health Data Science

Open Date: 2020-07-01

Close Date: 2028-06-30

Articles (6)

Year:

2023

Objectives Successful delivery of digital health interventions is affected by multiple real-world factors. These factors may be identified in routinely collected, ecologically valid data from these interventions. We propose ideas for exploring these data, focusing on interventions targeting complex, comorbid conditions. Materials and Methods This study retrospectively explores pre-post data collected between 2016 and 2019 from users of digital cognitive behavioral therapy (CBT)—containing psychoeducation and practical exercises—for substance use disorder (SUD) at UK addiction services. To identify factors associated with heterogenous user responses to the technology, we employed multivariable and multivariate regressions and random forest models of user-reported questionnaire data. Results The dataset contained information from 14 078 individuals of which 12 529 reported complete data at baseline and 2925 did so again after engagement with the CBT. Ninety-three percent screened positive for dependence on 1 of 43 substances at baseline, and 73% screened positive for anxiety or depression. Despite pre-post improvements independent of user sociodemographics, women reported more frequent and persistent symptoms of SUD, anxiety, and depression. Retention—minimum 2 use events recorded—was associated more with deployment environment than user characteristics. Prediction accuracy of post-engagement outcomes was acceptable (Area Under Curve [AUC]: 0.74–0.79), depending non-trivially on user characteristics. Discussion Traditionally, performance of digital health interventions is determined in controlled trials. Our analysis showcases multivariate models with which real-world data from these interventions can be explored and sources of user heterogeneity in retention and symptom reduction uncovered. Conclusion Real-world data from digital health interventions contain information on natural user-technology interactions which could enrich results from controlled trials.

Year:

2023

Year:

2022

Year:

2021

Year:

2020

Year:

2020

Collaborators (7)

Rachel Plachcinski

City, University of London

UNITED KINGDOM
View details

Beck Taylor

University of Birmingham

UNITED KINGDOM
View details

Kelly-Ann Eastwood

Honorary lecturer

Queen's University Belfast

UNITED KINGDOM
View details

Amaya Azcoaga-Lorenzo

University of St. Andrews

UNITED KINGDOM
View details

Holly Hope

The University of Manchester

UNITED KINGDOM
View details

Tatjana Sauka-Spengler

Professor of Developmental Genomics and Gene Regulation

University of Oxford

UNITED KINGDOM
View details

Stephanie Jones

University of Oxford

UNITED KINGDOM
View details
ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.